1. Home
  2. CBT vs CORT Comparison

CBT vs CORT Comparison

Compare CBT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$77.21

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$51.51

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBT
CORT
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
CBT
CORT
Price
$77.21
$51.51
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$70.00
$96.50
AVG Volume (30 Days)
264.8K
891.6K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
1.37
N/A
Revenue
$3,713,000,000.00
$761,407,000.00
Revenue This Year
N/A
$26.08
Revenue Next Year
$2.94
$26.98
P/E Ratio
$56.40
$56.10
Revenue Growth
N/A
12.79
52 Week Low
$58.33
$28.66
52 Week High
$83.71
$91.00

Technical Indicators

Market Signals
Indicator
CBT
CORT
Relative Strength Index (RSI) 61.26 75.91
Support Level $72.92 $32.95
Resistance Level $82.48 $75.20
Average True Range (ATR) 1.77 1.80
MACD 0.10 0.23
Stochastic Oscillator 80.63 97.88

Price Performance

Historical Comparison
CBT
CORT

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: